Compare Novavax Inc (NVAX) vs Unilever plc (UL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Unilever plc — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while Unilever plc trades at $62.18 (market cap $131.86B). The key difference: Unilever plc is far larger — about 101.4× Novavax Inc's market cap, and Unilever plc pays a 3.68% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | UL | |
|---|---|---|
Market Cap | $1.30B | $131.86B |
Sector | Health | Consumer Staples |
52-Week High | $11.19 | $74.59 |
52-Week Low | $6.22 | $55.05 |
Enterprise Value | $800.50M | $157.31B |
Dividend Yield | — | 3.68% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Unilever plc
Unilever is a diversified personal product (42% of 2021 sales by value), home care (20%), and packaged food (38%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Lipton teas, Axe and Dove skin products, and the TRESemme haircare brand. The firm has been acquisitive in recent years
Read more on UL →
